StonvexLoading…
StonvexStonvexStonvexCore line items from SANM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-27 | Annual 2024 2024-09-28 | Annual 2023 2023-09-30 | Annual 2022 2022-10-01 |
|---|---|---|---|---|
Revenue | $8.13B | $7.57B | $8.94B | $7.92B |
Operating Income | $354.57M | $335.49M | $455.66M | $349.48M |
Net Income | $245.89M | $222.54M | $309.97M | $240.38M |
EPS (Diluted) | $4.46 | $3.91 | $5.18 | $3.81 |
Total Assets | $5.86B | $4.82B | $4.87B | $4.84B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $926.27M | $625.86M | $667.57M | $529.86M |
Free Cash Flow OCF − CapEx | $473.30M | $228.99M | $43.80M | $192.22M |
Shares Outstanding | 53.40M | 53.92M | 56.83M | 57.39M |